Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H22N4O3 |
| Molecular Weight | 318.3709 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=C(OCCCCC2=NN=NN2)C=CC(C(C)=O)=C1O
InChI
InChIKey=MWYHLEQJTQJHSS-UHFFFAOYSA-N
InChI=1S/C16H22N4O3/c1-3-6-13-14(9-8-12(11(2)21)16(13)22)23-10-5-4-7-15-17-19-20-18-15/h8-9,22H,3-7,10H2,1-2H3,(H,17,18,19,20)
| Molecular Formula | C16H22N4O3 |
| Molecular Weight | 318.3709 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Originator
Sources: http://adisinsight.springer.com/drugs/800000075
Curator's Comment: # Eli Lilly
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Q9Y271 Gene ID: 10800.0 Gene Symbol: CYSLTR1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3981452 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2554766 |
Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Molecular basis for reduced estrone sulfate transport and altered modulator sensitivity of transmembrane helix (TM) 6 and TM17 mutants of multidrug resistance protein 1 (ABCC1). | 2009-07 |
|
| Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro. | 2004-10 |
|
| Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1. | 2004-04 |
|
| Leukotrienes mediate murine bronchopulmonary hyperreactivity, inflammation, and part of mucosal metaplasia and tissue injury induced by recombinant murine interleukin-13. | 2003-04 |
|
| Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine. | 2003-01-10 |
|
| Enhanced activity of Ca2+-activated K+ channels by 1-[2-hydroxy-3-propyl-4-[(1H-tetrazol-5-yl)butoxyl]phenyl] ethanone (LY-171883) in neuroendocrine and neuroblastoma cell lines. | 2002-08 |
|
| Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. | 2002-06 |
|
| Pharmacology of leukotriene receptor antagonists | 1998-06 |
|
| Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. | 1996-07 |
|
| In vivo characterization of zymosan-induced mouse peritoneal inflammation. | 1994-06 |
|
| Anti-leukotriene effects of WY-50,295 tromethamine in isolated guinea pig pulmonary tissues. | 1993-04-06 |
|
| Endogenously formed leukotriene C4 activates LTC4 receptors in guinea pig tracheal strips. | 1991-03-26 |
|
| Mechanism of phosgene-induced lung toxicity: role of arachidonate mediators. | 1990-11 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2554766
600 mg twice daily for 6 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1706765
LY171883 functioned primarily as a leukotriene receptor antagonist with minimal pharmacological activity attributable to its ability to potentiate isoprenaline. Relaxation of carbachol-contracted guinea-pig trachea by isoprenaline was enhanced by the three agents in a dose-dependent manner. A two-fold enhancement of isoprenaline-induced smooth muscle relaxation was produced by 2.5 microM IBMX, 28 microM LY171883, or 140 microM theophylline. LY171883 totally inhibited the response and had significant LTE4 receptor antagonist activity even at 10-fold lower concentrations.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:52:19 GMT 2025
by
admin
on
Mon Mar 31 17:52:19 GMT 2025
|
| Record UNII |
59762X5CLS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29712
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID7020344
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
75310
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
59762X5CLS
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
88107-10-2
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
6289
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
3969
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
CHEMBL162358
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
C74135
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
W-40
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
100000077788
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY | |||
|
SUB11184MIG
Created by
admin on Mon Mar 31 17:52:19 GMT 2025 , Edited by admin on Mon Mar 31 17:52:19 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |